Banque Cantonale Vaudoise Ionis Pharmaceuticals Inc Transaction History

Banque Cantonale Vaudoise

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$33.58 - $41.2 $29,516 - $36,214	-879 Reduced 68.73%	400 $14,000
Q4 2022 Feb 10, 2023	BUY	$37.12 - $46.52 $32,628 - $40,891	879 Added 219.75%	1,279 $48,000
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $82,896 - $113,400	-2,400 Reduced 85.71%	400 $16,000
Q1 2021 May 11, 2021	SELL	$42.51 - $63.78 $71,034 - $106,576	-1,671 Reduced 37.37%	2,800 $126,000
Q4 2020 Feb 05, 2021	SELL	$45.3 - $60.27 $543 - $723	-12 Reduced 0.27%	4,471 $253,000
Q3 2020 Oct 30, 2020	SELL	$47.45 - $62.95 $110,368 - $146,421	-2,326 Reduced 34.16%	4,483 $212,000
Q2 2020 Jul 22, 2020	BUY	$46.85 - $61.05 $115,204 - $150,121	2,459 Added 56.53%	6,809 $401,000
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $2,454 - $3,740	-59 Reduced 1.34%	4,350 $205,000
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $237,424 - $287,775	4,409 New	4,409 $266,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.